Analyze Diet
Animals : an open access journal from MDPI2023; 13(2); doi: 10.3390/ani13020227

Biomarkers of Intestinal Injury in Colic.

Abstract: Biomarkers are typically proteins, enzymes, or other molecular changes that are elevated or decreased in body fluids during the course of inflammation or disease. Biomarkers pose an extremely attractive tool for establishing diagnoses and prognoses of equine gastrointestinal colic, one of the most prevalent causes of morbidity and mortality in horses. This topic has received increasing attention because early diagnosis of some forms of severe colic, such as intestinal ischemia, would create opportunities for rapid interventions that would likely improve case outcomes. This review explores biomarkers currently used in equine medicine for colic, including acute phase proteins, proinflammatory cytokines, markers of endotoxemia, and tissue injury metabolites. To date, no single biomarker has been identified that is perfectly sensitive and specific for intestinal ischemia; however, L-lactate has been proven to be a very functional and highly utilized diagnostic tool. However, further exploration of other biomarkers discussed in this review may provide the key to accelerated identification, intervention, and better outcomes for horses suffering from severe colic.
Publication Date: 2023-01-07 PubMed ID: 36670767PubMed Central: PMC9854801DOI: 10.3390/ani13020227Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the potential of biomarkers in diagnosing and determining the prognosis of equine gastrointestinal colic – a common cause of illness and death in horses. It focuses on various biomarkers presently used in equine medicine for colic, reviews their effectiveness, and emphasizes the need for further exploration to improve the early diagnosis and treatment of severe colic in horses.

Understanding Biomarkers

  • Biomarkers are usually proteins, enzymes, or other molecular changes that increase or decrease in body fluids during inflammation or disease.
  • These biomarkers are helpful in establishing diagnoses and prognoses of certain diseases including equine gastrointestinal colic – a common disease that affects the well-being and survival of horses.

Role of Biomarkers in Equine Medicine

  • In equine medicine, various biomarkers such as acute phase proteins, proinflammatory cytokines, markers of endotoxemia, and tissue injury metabolites are used for detecting and treating colic.
  • Early diagnosis of some severe forms of colic, like intestinal ischemia, can lead to timely interventions, likely leading to improved case outcomes.

Evaluating the Effectiveness of Biomarkers

  • Despite the utilisation of various biomarkers, no single biomarker has been identified that is completely sensitive and specific for intestinal ischemia – a severe form of colic.
  • However, L-lactate has proven to be a highly functional and frequently used diagnostic tool in equine colic cases.

Need for Further Exploration

  • While current biomarkers are helping in diagnosing and treating colic in horses, the review reaffirms the need for further exploration of other biomarkers.
  • New research may provide the key to quicker identification, intervention, and better outcomes for horses suffering from severe colic.

Cite This Article

APA
Ludwig EK, Hobbs KJ, McKinney-Aguirre CA, Gonzalez LM. (2023). Biomarkers of Intestinal Injury in Colic. Animals (Basel), 13(2). https://doi.org/10.3390/ani13020227

Publication

ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 13
Issue: 2

Researcher Affiliations

Ludwig, Elsa K
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC 27606, USA.
Hobbs, Kallie J
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC 27606, USA.
McKinney-Aguirre, Caroline A
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC 27606, USA.
Gonzalez, Liara M
  • Department of Clinical Sciences, North Carolina State University, Raleigh, NC 27606, USA.

Grant Funding

  • T32 OD011130 / NIH HHS
  • U01 TR002953 / NCATS NIH HHS
  • U01TR002953-04 / NIH HHS
  • 2 T32 OD011130-16 / NIH HHS

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 106 references
  1. Trim C.M., Shepard M.K. Veterinary Anesthesia and Analgesia; Lumb and Jones. 5th ed. John Wiley & Sons; Ames, IA, USA: 2015. Horses with colic; pp. 867–885.
  2. Blikslager A.T.. Treatment of gastrointestinal ischemic injury. Vet. Clin. Equine Pract. 2003;19:715–727.
    doi: 10.1016/j.cveq.2003.08.004pubmed: 14740765google scholar: lookup
  3. Auer J., Stick J. Equine Surgery. Elsevier; St. Louis, MO, USA: 2019.
  4. Gerard M.P., Blikslager A.T., Roberts M.C., Tate L.P., Argenzio R.A.. The characteristics of intestinal injury peripheral to strangulating obstruction lesions in the equine small intestine. Equine Vet. J. 1999;31:331–335.
  5. Parry B.. Prognostic evaluation of equine colic cases. Compend. Contin. Educ. Pract. Vet. USA. 1986;8:S98–S104.
  6. Latson K.M., Nieto J.E., Beldomenico P.M., Snyder J.R.. Evaluation of peritoneal fluid lactate as a marker of intestinal ischaemia in equine colic. Equine Vet. J. 2005;37:342–346.
    doi: 10.2746/0425164054529319pubmed: 16028624google scholar: lookup
  7. Derikx J.P., Schellekens D.H., Acosta S.. Serological markers for human intestinal ischemia: A systematic review. Best Pract. Res. Clin. Gastroenterol. 2017;31:69–74.
    doi: 10.1016/j.bpg.2017.01.004pubmed: 28395790google scholar: lookup
  8. Chan T., Gu F.. Early diagnosis of sepsis using serum biomarkers. Expert Rev. Mol. Diagn. 2011;11:487–496.
    doi: 10.1586/erm.11.26pubmed: 21707457google scholar: lookup
  9. Lü X., Liu Y., Wang X., Qu J.. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients. Indian J. Med. Res. 2015;141:315.
    pmc: PMC4442329pubmed: 25963492
  10. Gunduz A., Turedi S., Mentese A., Karahan S.C., Hos G., Tatlı O., Turan I., Ucar U., Russell R.M., Topbas M.. Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: A preliminary study. Am. J. Emerg. Med. 2008;26:202–205.
    doi: 10.1016/j.ajem.2007.04.030pubmed: 18272103google scholar: lookup
  11. Ludewig S., Jarbouh R., Ardelt M., Mothes H., Rauchfuß F., Fahrner R., Zanow J., Settmacher U.. Bowel Ischemia in ICU Patients: Diagnostic Value of I-FABP Depends on the Interval to the Triggering Event. Gastroenterol. Res. Pract. 2017;2017:2795176.
    doi: 10.1155/2017/2795176pmc: PMC5467337pubmed: 28630622google scholar: lookup
  12. Memet O., Zhang L., Shen J.. Serological biomarkers for acute mesenteric ischemia. Ann. Transl. Med. 2019;7:394.
    doi: 10.21037/atm.2019.07.51pmc: PMC6736808pubmed: 31555708google scholar: lookup
  13. Peoc’h K., Corcos O.. Biomarkers for acute mesenteric ischemia diagnosis: State of the art and perspectives. Ann. Biol. Clin. 2019;77:415–421.
    doi: 10.1684/abc.2019.1449pubmed: 31225801google scholar: lookup
  14. Shearer T.R., Norby B., Carr E.A.. Peritoneal Fluid Lactate Evaluation in Horses With Nonstrangulating Versus Strangulating Small Intestinal Disease. J. Equine Vet. Sci. 2018;61:18–21.
  15. Acosta S., Nilsson T.. Current status on plasma biomarkers for acute mesenteric ischemia. J. Thromb. Thrombolysis. 2012;33:355–361.
    doi: 10.1007/s11239-011-0660-zpubmed: 22081293google scholar: lookup
  16. Cray C., Zaias J., Altman N.H.. Acute phase response in animals: A review. Comp. Med. 2009;59:517.
    pmc: PMC2798837pubmed: 20034426
  17. Crisman M.V., Scarratt W.K., Zimmerman K.L.. Blood proteins and inflammation in the horse. Vet. Clin. N. Am. Equine Pract. 2008;24:285–297.
    doi: 10.1016/j.cveq.2008.03.004pubmed: 18652956google scholar: lookup
  18. Bamias G., Cominelli F.. Cytokines and Intestinal Inflammation. Curr. Opin. Gastroenterol. 2016;32:437–442.
    doi: 10.1097/MOG.0000000000000315pubmed: 27673380google scholar: lookup
  19. Epstein F.H., Gabay C., Kushner I.. Acute-Phase Proteins and Other Systemic Responses to Inflammation. N. Engl. J. Med. 1999;340:448–454.
    pubmed: 9971870
  20. Ludwig E.K.. Equine Septic Arthritis and Serum Amyloid A. Ph.D. Thesis. Virginia Tech; Blacksburg, VA, USA: 2016.
  21. Gruys E., Toussaint M.J.M., Niewold T.A., Koopmans S.J.. Acute phase reaction and acute phase proteins. J. Zhejiang Univ. Sci. B. 2005;6:1045.
    doi: 10.1631/jzus.2005.B1045pmc: PMC1390650pubmed: 16252337google scholar: lookup
  22. Cerón J.J., Eckersall P.D., Martínez-Subiela S.. Acute phase proteins in dogs and cats: Current knowledge and future perspectives. Vet. Clin. Pathol. 2005;34:85–99.
  23. Cray C., Belgrave R.L.. Haptoglobin quantitation in serum samples from clinically normal and clinically abnormal horses. J. Equine Vet. Sci. 2014;34:337–340.
  24. Jacobsen S., Andersen P.. The acute phase protein serum amyloid A (SAA) as a marker of inflammation in horses. Equine Vet. Educ. 2007;19:38–46.
  25. Eckersall P.D., Duthie S., Toussaint M.J., Gruys E., Heegaard P., Alava M., Lipperheide C., Madec F.. Standardization of diagnostic assays for animal acute phase proteins. Adv. Vet. Med. 1999;41:643–655.
    pubmed: 9890051
  26. Nieto J.E., Macdonald M.H., Braim A.E.P., Aleman M.. Effect of lipopolysaccharide infusion on gene expression of inflammatory cytokines in normal horses in vivo. Equine Vet. J. 2009;7:717–719.
    doi: 10.2746/042516409X464780pubmed: 19927593google scholar: lookup
  27. Shahini A., Shahini A.. Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: Focus on the available therapeutic approaches and gut microbiome. J. Cell Commun. Signal. 2022:1–20.
    doi: 10.1007/s12079-022-00695-xpmc: PMC10030733pubmed: 36112307google scholar: lookup
  28. Peoc’H K., Nuzzo A., Guedj K., Paugam-Burtz C., Corcos O.. Diagnosis biomarkers in acute intestinal ischemic injury: So close, yet so far. Clin. Chem. Lab. Med. 2018;56:373–385.
    doi: 10.1515/cclm-2017-0291pubmed: 28841570google scholar: lookup
  29. Montagnana M., Danese E., Lippi G.. Biochemical markers of acute intestinal ischemia: Possibilities and limitations. Ann. Transl. Med. 2018;6:341.
    doi: 10.21037/atm.2018.07.22pmc: PMC6174180pubmed: 30306080google scholar: lookup
  30. Barton M.H., Collatos C.. Tumor Necrosis Factor and Interleukin-6 Activity and Endotoxin Concentration in Peritoneal Fluid and Blood of Horses with Acute Abdominal Disease. J. Vet. Intern. Med. 1999;13:457–464.
  31. Steverink P., Sturk A., Rutten V., Wagenaar-Hilbers J., Klein W., van der Velden M., Németh F.. Endotoxin, interleukin-6 and tumor necrosis factor concentrations in equine acute abdominal disease: Relation to clinical outcome. J. Endotoxin Res. 1995;2:289–299.
  32. El-Deeb W., Fayez M., Elsohaby I., Mkrtchyan H.V., Alhaider A.. Changes in blood biomarkers in Arabian horses with Clostridium difficile-induced enterocolitis. Comp. Immunol. Microbiol. Infect. Dis. 2020;73:101525.
    doi: 10.1016/j.cimid.2020.101525pubmed: 32877870google scholar: lookup
  33. la Garza F.J.G.D., Ibarra-Hernández J.M., Cordero-Pérez P., Villegas-Quintero P., Villarreal-Ovalle C.I., Torres-González L., Oliva-Sosa N.E., Alarcón-Galván G., Fernández-Garza N.E., Muñoz-Espinosa L.E.. Temporal relationship of serum markers and tissue damage during acute intestinal ischemia/reperfusion. Clinics 2013;68:1034–1038.
    doi: 10.6061/clinics/2013(07)23pmc: PMC3715035pubmed: 23917671google scholar: lookup
  34. Yamamoto S., Tanabe M., Wakabayashi G., Shimazu M., Matsumoto K., Kitajima M.. The role of tumor necrosis factor-alpha and interleukin-1beta in ischemia-reperfusion injury of the rat small intestine. J. Surg. Res. 2001;99:134–141.
    doi: 10.1006/jsre.2001.6106pubmed: 11421615google scholar: lookup
  35. Yan G.-T., Hao X.-H., Xue H., Wang L.-H., Li Y.-L., Shi L.-P.. Interleukin-1beta expression and phospholipase A (2) activation after intestinal ischemia/reperfusion injury. Acta Physiol. Sin. 2002;54:28–32.
    pubmed: 11930237
  36. Wyble C.W., Desai T.R., Clark E.T., Hynes K.L., Gewertz B.L.. Physiologic concentrations of TNFalpha and IL-1beta released from reperfused human intestine upregulate E-selectin and ICAM-1. J. Surg. Res. 1996;63:333–338.
    doi: 10.1006/jsre.1996.0271pubmed: 8661221google scholar: lookup
  37. Dionne S., Hiscott J., D’agata I., Duhaime A., Seidman E.G.. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig. Dis. Sci. 1997;42:1557–1566.
    doi: 10.1023/A:1018895500721pubmed: 9246063google scholar: lookup
  38. Reimund J.M., Wittersheim C., Dumont S., Muller C.D., Kenney J.S., Baumann R., Poindron P., Duclos B.. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn’s disease. Gut 1996;39:684–689.
    doi: 10.1136/gut.39.5.684pmc: PMC1383392pubmed: 9026483google scholar: lookup
  39. Teschner D., Rieger M., Koopmann C., Gehlen H.. Procalcitonin bei Pferden mit akuter Kolik. Pferdeheilkunde 2015;31:317–377.
  40. Sands B.E.. Biomarkers of Inflammation in Inflammatory Bowel Disease. Gastroenterology 2015;149:1275–1285.e1272.
    doi: 10.1053/j.gastro.2015.07.003pubmed: 26166315google scholar: lookup
  41. Morris D., Moore J., Crowe N.. Serum tumor necrosis factor activity in horses with colic attributable to gastrointestinal tract disease. Am. J. Vet. Res. 1991;52:1565–1569.
    pubmed: 1767972
  42. Copas V.E.N., Durham A.E., Stratford C.H., McGorum B.C., Waggett B., Pirie R.S.. In equine grass sickness, serum amyloid A and fibrinogen are elevated, and can aid differential diagnosis from non-inflammatory causes of colic. Vet. Rec. 2013;172:395.
    doi: 10.1136/vr.101224pubmed: 23428423google scholar: lookup
  43. Forbes G., Sorich E., Nath L., Church S., Savage C., Bailey S.. Activin A as a novel biomarker of equine inflammatory abdominal disease: Preliminary findings. Vet. J. 2011;190:e154–e156.
    doi: 10.1016/j.tvjl.2011.01.006pubmed: 21339074google scholar: lookup
  44. Phillips D.J., de Kretser D.M., Hedger M.P.. Activin and related proteins in inflammation: Not just interested bystanders. Cytokine Growth Factor Rev. 2009;20:153–164.
    doi: 10.1016/j.cytogfr.2009.02.007pubmed: 19261538google scholar: lookup
  45. Hübner G., Brauchle M., Gregor M., Werner S.. Activin A: A novel player and inflammatory marker in inflammatory bowel disease?. Lab. Investig. J. Tech. Methods Pathol. 1997;77:311–318.
    pubmed: 9354766
  46. Markogiannakis H., Memos N., Messaris E., Dardamanis D., Larentzakis A., Papanikolaou D., Zografos G.C., Manouras A.. Predictive value of procalcitonin for bowel ischemia and necrosis in bowel obstruction. Surgery 2011;149:394–403.
    doi: 10.1016/j.surg.2010.08.007pubmed: 20869092google scholar: lookup
  47. Cosse C., Sabbagh C., Browet F., Mauvais F., Rebibo L., Zogheib E., Chatelain D., Kamel S., Regimbeau J.M.. Serum value of procalcitonin as a marker of intestinal damages: Type, extension, and prognosis. Surg. Endosc. 2015;29:3132–3139.
    doi: 10.1007/s00464-014-4038-0pubmed: 25701059google scholar: lookup
  48. Cosse C., Sabbagh C., Kamel S., Galmiche A., Regimbeau J.-M.. Procalcitonin and intestinal ischemia: A review of the literature. World J. Gastroenterol. WJG 2014;20:17773.
    doi: 10.3748/wjg.v20.i47.17773pmc: PMC4273127pubmed: 25548475google scholar: lookup
  49. Bonelli F., Meucci V., Divers T., Jose-Cunilleras E., Corazza M., Tognetti R., Guidi G., Intorre L., Sgorbini M.. Plasma procalcitonin concentration in healthy horses and horses affected by systemic inflammatory response syndrome. J. Vet. Intern. Med. 2015;29:1689–1691.
    doi: 10.1111/jvim.13640pmc: PMC4895682pubmed: 26474412google scholar: lookup
  50. Nocera I., Bonelli F., Vitale V., Meucci V., Conte G., Jose-Cunilleras E., Gracia-Calvo L., Sgorbini M.. Evaluation of plasmatic procalcitonin in healthy, and in systemic inflammatory response syndrome (sirs) negative or positive colic horses. Animals 2021;11:2015.
    doi: 10.3390/ani11072015pmc: PMC8300415pubmed: 34359143google scholar: lookup
  51. Kilcoyne I., Nieto J.E., Dechant J.E.. Diagnostic value of plasma and peritoneal fluid procalcitonin concentrations in horses with strangulating intestinal lesions. J. Am. Vet. Med. Assoc. 2020;256:927–933.
    doi: 10.2460/javma.256.8.927pubmed: 32223710google scholar: lookup
  52. Pihl T., Scheepers E., Sanz M., Goddard A., Page P., Toft N., Andersen P., Jacobsen S.. Influence of disease process and duration on acute phase proteins in serum and peritoneal fluid of horses with colic. J. Vet. Intern. Med. 2015;29:651–658.
    doi: 10.1111/jvim.12542pmc: PMC4895517pubmed: 25644457google scholar: lookup
  53. Pihl T.H., Scheepers E., Sanz M., Goddard A., Page P., Toft N., Kjelgaard-Hansen M., Andersen P.H., Jacobsen S.. Acute-phase proteins as diagnostic markers in horses with colic. J. Vet. Emerg. Crit. Care. 2016;26:664–674.
    doi: 10.1111/vec.12504pubmed: 27384962google scholar: lookup
  54. Milne E., Doxey D., Kent J., Pemberton A.. Acute phase proteins in grass sickness (equine dysautonomia). Res. Vet. Sci. 1991;50:273–278.
    doi: 10.1016/0034-5288(91)90123-6pubmed: 1715594google scholar: lookup
  55. Aitken M.R., Stefanovski D., Southwood L.L.. Serum amyloid A concentration in postoperative colic horses and its association with postoperative complications. Vet. Surg. 2019;48:143–151.
    doi: 10.1111/vsu.13133pubmed: 30499192google scholar: lookup
  56. Long A.. Clinical insights: Clinicopathological parameters for diagnosing and predicting outcome of horses with colic. Equine Vet. J. 2022;54:1005–1010.
    doi: 10.1111/evj.13871pubmed: 36044554google scholar: lookup
  57. Long A., Nolen-Walston R.. Equine inflammatory markers in the twenty-first century: A focus on serum amyloid a. Vet. Clin. Equine Pract. 2020;36:147–160.
    doi: 10.1016/j.cveq.2019.12.005pmc: PMC7135104pubmed: 32007299google scholar: lookup
  58. Daniel A.J., Leise B.S., Burgess B.A., Morley P.S., Cloninger M., Hassel D.M.. Concentrations of serum amyloid A and plasma fibrinogen in horses undergoing emergency abdominal surgery. J. Vet. Emerg. Crit. Care. 2016;26:344–351.
    doi: 10.1111/vec.12365pubmed: 26274017google scholar: lookup
  59. Minamijima Y., Tozaki T., Kuroda T., Urayama S., Nomura M., Yamamoto K.. A comprehensive and comparative proteomic analysis of horse serum proteins in colitis. Equine Vet. J. 2022;54:1039–1046.
    doi: 10.1111/evj.13554pubmed: 35000251google scholar: lookup
  60. Westerman T.L., Foster C.M., Tornquist S.J., Poulsen K.P.. Evaluation of serum amyloid A and haptoglobin concentrations as prognostic indicators for horses with colic. J. Am. Vet. Med. Assoc. 2016;248:935–940.
    doi: 10.2460/javma.248.8.935pubmed: 27031421google scholar: lookup
  61. Bardell D., Milner P.I., Goljanek-Whysall K., Peffers M.J.. Differences in plasma and peritoneal fluid proteomes identifies potential biomarkers associated with survival following strangulating small intestinal disease. Equine Vet. J. 2019;51:727–732.
    doi: 10.1111/evj.13094pubmed: 30854696google scholar: lookup
  62. De Cozar M., Sherlock C., Knowles E., Mair T.. Serum amyloid A and plasma fibrinogen concentrations in horses following emergency exploratory celiotomy. Equine Vet. J. 2020;52:59–66.
    doi: 10.1111/evj.13117pubmed: 30912857google scholar: lookup
  63. Vandenplas M., Moore J., Barton M.. Concentrations of serum amyloid A and lipopolysaccharide-binding protein in horses with colic. Am. J. Vet. Res. 2005;66:1509–1516.
    doi: 10.2460/ajvr.2005.66.1509pubmed: 16261823google scholar: lookup
  64. Pihl T.H., Andersen P.H., Kjelgaard-Hansen M.. Serum amyloid A and haptoglobin concentrations in serum and peritoneal fluid of healthy horses and horses with acute abdominal pain. Vet. Clin. Pathol. 2013;42:177–183.
    doi: 10.1111/vcp.12031pubmed: 23577834google scholar: lookup
  65. Ludwig E.K., Wiese R.B., Graham M.R., Tyler A.J., Settlage J.M., Werre S.R., Petersson-Wolfe C.S., Kanevsky-Mullarky I., Dahlgren L.A.. Serum and synovial fluid serum amyloid A response in equine models of synovitis and septic arthritis. Vet. Surg. 2016;45:859–867.
    doi: 10.1111/vsu.12531pubmed: 27580707google scholar: lookup
  66. Dondi F., Lukacs R.M., Gentilini F., Rinnovati R., Spadari A., Romagnoli N.. Serum amyloid A, haptoglobin, and ferritin in horses with colic: Association with common clinicopathological variables and short-term outcome. Vet. J. 2015;205:50–55.
    doi: 10.1016/j.tvjl.2015.03.015pubmed: 25981935google scholar: lookup
  67. Cray C.. Biomarkers of inflammation in exotic pets. J. Exot. Pet Med. 2013;22:245–250.
  68. López-Martínez M.J., Franco-Martínez L., Martínez-Subiela S., Cerón J.J.. Biomarkers of sepsis in pigs, horses and cattle: From acute phase proteins to procalcitonin. Anim. Health Res. Rev. 2022;23:82–99.
    doi: 10.1017/S1466252322000019pubmed: 35795920google scholar: lookup
  69. Borges A.S., Divers T.J., Stokol T., Mohammed O.H.. Serum iron and plasma fibrinogen concentrations as indicators of systemic inflammatory diseases in horses. J. Vet. Intern. Med. 2007;21:489–494.
  70. Collatos C., Barton M.H., Moore J.N.. Fibrinolytic activity in plasma from horses with gastrointestinal diseases: Changes associated with diagnosis, surgery, and outcome. J. Vet. Intern. Med. 1995;9:18–23.
  71. Jain S., Gautam V., Naseem S.. Acute-phase proteins: As diagnostic tool. J. Pharm. Bioallied Sci. 2011;3:118.
    doi: 10.4103/0975-7406.76489pmc: PMC3053509pubmed: 21430962google scholar: lookup
  72. Vermeire S., Van Assche G., Rutgeerts P.. Laboratory markers in IBD: Useful, magic, or unnecessary toys?. Gut 2006;55:426–431.
    doi: 10.1136/gut.2005.069476pmc: PMC1856093pubmed: 16474109google scholar: lookup
  73. Takiguchi M., Fujinaga T., Naiki M., Mizuno S., Otomo K.. Isolation, characterization, and quantitative analysis of C-reactive protein from horses. Am. J. Vet. Res. 1990;51:1215–1220.
    pubmed: 2117410
  74. Yamashita K., Fujinaga T., Okumura M., Takiguchi M., Tsunoda N., Mizuno S.. Serum C-reactive protein (CRP) in horses: The effect of aging, sex, delivery and inflammations on its concentration. J. Vet. Med. Sci. 1991;53:1019–1024.
    doi: 10.1292/jvms.53.1019pubmed: 1790210google scholar: lookup
  75. Matsumoto S., Sekine K., Funaoka H., Yamazaki M., Shimizu M., Hayashida K., Kitano M.. Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. J. Br. Surg. 2014;101:232–238.
    doi: 10.1002/bjs.9331pubmed: 24402763google scholar: lookup
  76. Kong C., Li S.-M., Yang H., Xiao W.-D., Cen Y.-Y., Wu Y., Li W.-M., Sun D.-L., Xu P.-Y.. Screening and combining serum biomarkers to improve their diagnostic performance in the detection of intestinal barrier dysfunction in patients after major abdominal surgery. Ann. Transl. Med. 2019;7:388.
    doi: 10.21037/atm.2019.07.102pmc: PMC6736800pubmed: 31555702google scholar: lookup
  77. Schellekens D.H.S.M., Grootjans J., Dello S.A.W.G., Van Bijnen A.A., Van Dam R.M., DeJong C.H.C., Derikx J.P.M., Buurman W.A.. Plasma intestinal fatty acid-binding protein levels correlate with morphologic epithelial intestinal damage in a human translational ischemia-reperfusion model. J. Clin. Gastroenterol. 2014;48:253–260.
    doi: 10.1097/MCG.0b013e3182a87e3epubmed: 24100750google scholar: lookup
  78. Sun D.-L., Cen Y.-Y., Li S.-M., Li W.-M., Lu Q.-P., Xu P.-Y.. Accuracy of the serum intestinal fatty-acid-binding protein for diagnosis of acute intestinal ischemia: A meta-analysis. Nat. Sci. Rep. 2016;6:srep34371.
    doi: 10.1038/srep34371pmc: PMC5041130pubmed: 27681959google scholar: lookup
  79. Gollin G., Marks C., Marks W.H.. Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery 1993;113:545–551.
    pubmed: 8488474
  80. Nieto J.E., Aldridge B.M., Beldomenico P.M., Aleman M., Snyder J.R.. Characterization of equine intestinal fatty acid binding protein and its use in managing horses with colic. Am. J. Vet. Res. 2005;66:223–232.
    doi: 10.2460/ajvr.2005.66.223pubmed: 15757119google scholar: lookup
  81. Naito Y., Yoshikawa T.. Role of matrix metalloproteinases in inflammatory bowel disease. Mol. Asp. Med. 2005;26:379–390.
    doi: 10.1016/j.mam.2005.07.009pubmed: 16112187google scholar: lookup
  82. Barton A.K., Richter I.-G., Ahrens T., Merle R., Alalwani A., Lilge S., Purschke K., Barnewitz D., Gehlen H.. MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic. Mediat. Inflamm. 2021;2021:9501478.
    doi: 10.1155/2021/9501478pmc: PMC7803393pubmed: 33488296google scholar: lookup
  83. Rosário H.S., Waldo S.W., Becker S.A., Schmid-Schönbein G.W.. Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat. Am. J. Pathol. 2004;164:1707–1716.
  84. Lillich J.D., Ray-Miller W., Silver K., Davis E.G., Schultz B.D.. Intra-abdominal hyaluronan concentration in peritoneal fluid of horses with sudden signs of severe abdominal pain. Am. J. Vet. Res. 2011;72:1666–1673.
    doi: 10.2460/ajvr.72.12.1666pmc: PMC4487920pubmed: 22126696google scholar: lookup
  85. Dogné S., Flamion B.. Endothelial glycocalyx impairment in disease: Focus on hyaluronan shedding. Am. J. Pathol. 2020;190:768–780.
    doi: 10.1016/j.ajpath.2019.11.016pubmed: 32035885google scholar: lookup
  86. Lennon F.E., Singleton P.A.. Hyaluronan regulation of vascular integrity. Am. J. Cardiovasc. Dis. 2011;1:200.
    pmc: PMC3253523pubmed: 22254199
  87. Hundhausen C., Schneckmann R., Ostendorf Y., Rimpler J., von Glinski A., Kohlmorgen C., Pasch N., Rolauer L., von Ameln F., Eckermann O.. Endothelial hyaluronan synthase 3 aggravates acute colitis in an experimental model of inflammatory bowel disease. Matrix Biol. 2021;102:20–36.
    doi: 10.1016/j.matbio.2021.08.001pubmed: 34464693google scholar: lookup
  88. Arnalich F., Maldifassi M.C., Ciria E., Quesada A., Codoceo R., Herruzo R., Garcia-Cerrada C., Montoya F., Vazquez J.J., López-Collazo E.. Association of cell-free plasma DNA with perioperative mortality in patients with suspected acute mesenteric ischemia. Clin. Chim. Acta. 2010;411:1269–1274.
    doi: 10.1016/j.cca.2010.05.017pubmed: 20478285google scholar: lookup
  89. Rainer T.H., Chan A.K., Lee L.L., Yim V.W., Lam N.Y., Yeung S., Graham C.A., Lo D.Y.. Use of plasma DNA to predict mortality and need for intensive care in patients with abdominal pain. Clin. Chim. Acta. 2008;398:113–117.
    doi: 10.1016/j.cca.2008.08.022pubmed: 18801348google scholar: lookup
  90. Troia R., Giunti M., Calipa S., Goggs R.. Cell-Free DNA, high-mobility group box-1, and procalcitonin concentrations in dogs with gastric dilatation–volvulus syndrome. Front. Vet. Sci. 2018;5:67.
    doi: 10.3389/fvets.2018.00067pmc: PMC5900424pubmed: 29686994google scholar: lookup
  91. Bayless R.L., Cooper B.L., Sheats M.K.. Investigation of plasma cell-free DNA as a potential biomarker in horses. J. Vet. Diagn. Investig. 2022;34:402–406.
    doi: 10.1177/10406387221078047pmc: PMC9254060pubmed: 35168428google scholar: lookup
  92. Underwood C., Southwood L.L., Walton R.M., Johnson A.L.. Hepatic and metabolic changes in surgical colic patients: A pilot study. J. Vet. Emerg. Crit. Care. 2010;20:578–586.
  93. Rodríguez-Pozo M.L., Armengou L., Viu J., Ríos J., Jose-Cunilleras E.. Peritoneal bile acids concentration in adult horses with hepatic and gastrointestinal disorders. Equine Vet. J. 2022;54:914–921.
    doi: 10.1111/evj.13538pubmed: 34743363google scholar: lookup
  94. Roth M., Jaquet P.Y., Rohner A.. Increase of creatine kinase and lactate dehydrogenase in the serum of rats submitted to experimental intestinal infarction. Clin. Chim. Acta. 1989;183:65–69.
    doi: 10.1016/0009-8981(89)90273-8pubmed: 2766557google scholar: lookup
  95. Liao X.P., She Y.X., Shi C.R., Li M.. Changes in body fluid markers in intestinal ischemia. J. Pediatr. Surg. 1995;30:1412–1415.
    doi: 10.1016/0022-3468(95)90394-1pubmed: 8786476google scholar: lookup
  96. Di Filippo P.A., Santana A.E., Nogueira A.F.S., Anai L.A., Campos Filho E.. Características celulares e bioquímicas do líquido peritoneal de equinos submetidos à obstrução experimental do duodeno, íleo e cólon maior. Arq. Bras. Med. Veter. Zootec. 2009;61:1281–1289.
  97. Kilcoyne I., Nieto J.E., Dechant J.E.. Predictive value of plasma and peritoneal creatine kinase in horses with strangulating intestinal lesions. Vet. Surg. 2019;48:152–158.
    doi: 10.1111/vsu.13147pubmed: 30588637google scholar: lookup
  98. Smith S.M., Eng R.H., Buccini F.. Use of D-lactic acid measurements in the diagnosis of bacterial infections. J. Infect. Dis. 1986;154:658–664.
    doi: 10.1093/infdis/154.4.658pubmed: 3528318google scholar: lookup
  99. Evennett N.J., Petrov M.S., Mittal A., Windsor J.A.. Systematic review and pooled estimates for the diagnostic accuracy of serological markers for intestinal ischemia. World J. Surg. 2009;33:1374–1383.
    doi: 10.1007/s00268-009-0074-7pubmed: 19424744google scholar: lookup
  100. Sapin V., Nicolet L., Aublet-Cuvelier B., Sangline F., Roszyk L., Dastugue B., Gazuy N., Deteix P., Souweine B.. Rapid decrease in plasma D-lactate as an early potential predictor of diminished 28-day mortality in critically ill septic shock patients. Clin. Chem. Lab. Med. CCLM. 2006;44:492–496.
    doi: 10.1515/CCLM.2006.086pubmed: 16599846google scholar: lookup
  101. Marcos M.A., Vila J., Gratacos J., Brancos M.A., de Anta M.T.J.. Determination of D-lactate concentration for rapid diagnosis of bacterial infections of body fluids. Eur. J. Clin. Microbiol. Infect. Dis. 1991;10:966–969.
    doi: 10.1007/BF02005455pubmed: 1794370google scholar: lookup
  102. Yamout S.Z., Nieto J.E., Beldomenico P., DeChant J.E., Lejeune S., Snyder J.R.. Peritoneal and plasma D-lactate concentrations in horses with colic. Vet. Surg. 2011;40:817–824.
  103. Nappert G., Johnson P.J.. Determination of the acid-base status in 50 horses admitted with colic between December 1998 and May 1999. Can. Vet. J. 2001;42:703.
    pmc: PMC1476611pubmed: 11565369
  104. Henderson I.. Diagnostic and prognostic use of L-lactate measurement in equine practice. Equine Vet. Educ. 2013;25:468–475.
    doi: 10.1111/eve.12033google scholar: lookup
  105. Delesalle C., Dewulf J., Lefebvre R.A., Schuurkes J.A., Proot J., Lefere L., Deprez P.. Determination of lactate concentrations in blood plasma and peritoneal fluid in horses with colic by an Accusport analyzer. J. Vet. Intern. Med. 2007;21:293–301.
  106. Peloso J.G., Cohen N.D.. Use of serial measurements of peritoneal fluid lactate concentration to identify strangulating intestinal lesions in referred horses with signs of colic. J. Am. Vet. Med. Assoc. 2012;240:1208–1217.
    doi: 10.2460/javma.240.10.1208pubmed: 22559111google scholar: lookup